PROCTER & GAMBLE HEALTH | PFIZER | PROCTER & GAMBLE HEALTH/ PFIZER |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.7 | 37.5 | 92.5% | View Chart |
P/BV | x | 10.6 | 5.9 | 180.3% | View Chart |
Dividend Yield | % | 2.0 | 1.7 | 117.9% |
PROCTER & GAMBLE HEALTH PFIZER |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
PFIZER Mar-23 |
PROCTER & GAMBLE HEALTH/ PFIZER |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 4,662 | 115.1% | |
Low | Rs | 3,883 | 3,407 | 114.0% | |
Sales per share (Unadj.) | Rs | 740.7 | 530.0 | 139.8% | |
Earnings per share (Unadj.) | Rs | 138.2 | 136.4 | 101.4% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 159.4 | 97.3% | |
Dividends per share (Unadj.) | Rs | 95.00 | 70.00 | 135.7% | |
Avg Dividend yield | % | 2.1 | 1.7 | 118.4% | |
Book value per share (Unadj.) | Rs | 447.6 | 701.0 | 63.9% | |
Shares outstanding (eoy) | m | 16.60 | 45.75 | 36.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 7.6 | 82.0% | |
Avg P/E ratio | x | 33.5 | 29.6 | 113.1% | |
P/CF ratio (eoy) | x | 29.8 | 25.3 | 117.8% | |
Price / Book Value ratio | x | 10.3 | 5.8 | 179.5% | |
Dividend payout | % | 68.7 | 51.3 | 133.9% | |
Avg Mkt Cap | Rs m | 76,761 | 184,576 | 41.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 3,317 | 62.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 24,248 | 50.7% | |
Other income | Rs m | 184 | 1,011 | 18.2% | |
Total revenues | Rs m | 12,480 | 25,258 | 49.4% | |
Gross profit | Rs m | 3,247 | 8,420 | 38.6% | |
Depreciation | Rs m | 281 | 1,055 | 26.6% | |
Interest | Rs m | 8 | 135 | 5.7% | |
Profit before tax | Rs m | 3,142 | 8,240 | 38.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 2,001 | 42.3% | |
Profit after tax | Rs m | 2,295 | 6,239 | 36.8% | |
Gross profit margin | % | 26.4 | 34.7 | 76.0% | |
Effective tax rate | % | 27.0 | 24.3 | 111.1% | |
Net profit margin | % | 18.7 | 25.7 | 72.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 24,933 | 47.0% | |
Current liabilities | Rs m | 6,791 | 6,574 | 103.3% | |
Net working cap to sales | % | 40.0 | 75.7 | 52.9% | |
Current ratio | x | 1.7 | 3.8 | 45.5% | |
Inventory Days | Days | 263 | 93 | 281.2% | |
Debtors Days | Days | 343 | 2 | 15,038.2% | |
Net fixed assets | Rs m | 10,617 | 13,780 | 77.0% | |
Share capital | Rs m | 166 | 458 | 36.3% | |
"Free" reserves | Rs m | 7,265 | 31,616 | 23.0% | |
Net worth | Rs m | 7,431 | 32,073 | 23.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 39,031 | 57.2% | |
Interest coverage | x | 409.1 | 62.1 | 658.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.6 | 88.6% | |
Return on assets | % | 10.3 | 16.3 | 63.1% | |
Return on equity | % | 30.9 | 19.5 | 158.7% | |
Return on capital | % | 42.4 | 26.1 | 162.3% | |
Exports to sales | % | 0 | 2.8 | 0.0% | |
Imports to sales | % | 13.1 | 0 | 37,687.9% | |
Exports (fob) | Rs m | NA | 688 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 8 | 19,111.9% | |
Fx inflow | Rs m | 1,465 | 688 | 213.0% | |
Fx outflow | Rs m | 1,605 | 8 | 19,111.9% | |
Net fx | Rs m | -140 | 679 | -20.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 3,557 | 66.4% | |
From Investments | Rs m | -215 | -361 | 59.6% | |
From Financial Activity | Rs m | -985 | -3,458 | 28.5% | |
Net Cashflow | Rs m | 1,160 | -262 | -443.5% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 51.8 | 63.9 | 81.1% | |
Indian inst/Mut Fund | % | 20.0 | 18.7 | 107.1% | |
FIIs | % | 6.2 | 3.3 | 188.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 36.1 | 133.5% | |
Shareholders | 56,778 | 109,214 | 52.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Pfizer | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.51% | -0.78% | 1.03% |
1-Month | -0.93% | -3.69% | 1.10% |
1-Year | 0.82% | 8.81% | 53.75% |
3-Year CAGR | -8.69% | -7.20% | 14.67% |
5-Year CAGR | 4.87% | 5.47% | 19.26% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Pfizer share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Pfizer the stake stands at 63.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Pfizer.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Pfizer.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.